Dr. Reddy's Laboratories Limited (DRREDDY) — Financial Results | 5 November 2025

· NSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings

Dr. Reddy's Laboratories filed a notice regarding loss of share certificates on November 5, 2025, published in Business Standard and Nava Telangana newspapers. The filing is a regulatory disclosure under SEBI Listing Obligations requiring shareholders who claim lost certificates to lodge claims within 15 days of publication. No financial performance data is contained in this filing—it is purely an administrative notice for share certificate replacement.

📄 View Original Announcement (PDF)

About Dr. Reddy's Laboratories Limited (DRREDDY)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,11,568.6 Cr P/E: 20.0 ROE: 16.6% ROCE: 19.7%

View full DRREDDY stock details →

📡 Get AI alerts when DRREDDY files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track DRREDDY — Free

📊 More DRREDDY filings

See all DRREDDY filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when DRREDDY files new disclosures

Track DRREDDY filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track DRREDDY — Free

Free account · 2 AI queries/day